Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ocrelizumab dose selection for treatment of pediatric relapsing-remitting multiple sclerosis: results of the OPERETTA I study.
Mar S, Valeriani M, Steinborn B, Schreiner T, Waubant E, Filippi M, Kotulska K, Mazurkiewicz-Beldzinska M, El Azzouzi B, Lin CJ, Shen YA, Kletzl H, Evershed J, Hogea A, Manlius C, Bonati U, Banwell B. Mar S, et al. J Neurol. 2025 Jan 15;272(2):137. doi: 10.1007/s00415-024-12879-z. J Neurol. 2025. PMID: 39812825 Free PMC article.
Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States.
Wilson E, Meeks HD, Barney BJ, Waltz M, Canenguez K, Casper TC, Rose JW, Rodriguez M, Tillema JM, Chitnis T, Gorman MP, Rensel M, Abrams AW, Krupp LB, Lotze TE, Fisher KS, Shukla NM, Schreiner TL, Mar SS, Waubant E, Virupakshaiah A, Wheeler YS, Ness JM, Benson LA; as the United States Network of Pediatric Multiple Sclerosis Centers. Wilson E, et al. Among authors: mar ss. Neurology. 2024 Dec 10;103(11):e209991. doi: 10.1212/WNL.0000000000209991. Epub 2024 Nov 12. Neurology. 2024. PMID: 39531607
Characteristics and predictors of disease course in children initially presenting with ADEM.
Rutatangwa A, Aaen G, Krysko KM, Belman A, Benson LA, Chitnis T, Gorman M, Goyal M, Graves JS, Wheeler Y, Krupp L, Lotze T, Mar S, Ness J, Rensel M, Rodriguez M, Rose J, Schreiner T, Tillema JM, Weinstock-Guttman B, Waltz M, Casper TC, Waubant E; U.S. Network of Pediatric MS Centers. Rutatangwa A, et al. Among authors: mar s. Mult Scler Relat Disord. 2023 Oct 15;80:105075. doi: 10.1016/j.msard.2023.105075. Online ahead of print. Mult Scler Relat Disord. 2023. PMID: 39491412
The Multiple Sclerosis Prodrome in a Retrospective Pediatric Cohort.
Barter K, Sharayah S, Mange U, Gaudioso CM, Schanzer N, Keuchel C, Zolno R, Mar S. Barter K, et al. Among authors: mar s. Pediatr Neurol. 2024 Dec;161:144-148. doi: 10.1016/j.pediatrneurol.2024.09.005. Epub 2024 Sep 10. Pediatr Neurol. 2024. PMID: 39383588
Transcriptional coactivator MED15 is required for beta cell maturation.
Kadhim AZ, Vanderkruk B, Mar S, Dan M, Zosel K, Xu EE, Spencer RJ, Sasaki S, Cheng X, Sproul SLJ, Speckmann T, Nian C, Cullen R, Shi R, Luciani DS, Hoffman BG, Taubert S, Lynn FC. Kadhim AZ, et al. Among authors: mar s. Nat Commun. 2024 Oct 8;15(1):8711. doi: 10.1038/s41467-024-52801-9. Nat Commun. 2024. PMID: 39379383 Free PMC article.
Distinct plasma lipids predict axonal injury and multiple sclerosis activity.
Schoeps VA, Bhargava P, Virupakshaiah A, Ladakis DC, Moseley C, Chong J, Aaen G, Graves JS, Benson L, Gorman MP, Rensel M, Abrams A, Mar S, Lotze TE, Chitnis T, Waldman A, Krupp L, Rodriguez M, Tillema JM, Rose J, Schreiner T, Qureshi F, Peterson S, Barcellos LF, Casper TC, Newman J, Borkowski K, Waubant E; US Network of Pediatric MS Centers. Schoeps VA, et al. Among authors: mar s. J Neurol Neurosurg Psychiatry. 2025 Jan 16;96(2):150-157. doi: 10.1136/jnnp-2024-333652. J Neurol Neurosurg Psychiatry. 2025. PMID: 39266284
143 results